Health
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use
Johnson & Johnson and BARDA Together Commit More than $1 Billion to Novel Coronavirus Vaccine Research and Development; Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest bySeptember 2020 Johnson & Johnson Will Establish New U.S. Vaccine Manufacturing Capab...
Alphamab Oncology, Simcere and 3D Medicines Announce Partnership to Develop and Commercialize Subcutaneous Injectable anti-PD-L1 Antibody for Oncology Indications in Mainland China
SUZHOU, China, March 30, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966HK) announced today that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Jiangsu Alphamab"), a wholly-owned subsidiary of the Company, has established strategic partnership with Simcere and 3D Medicines (Beijing) Co....
Hotels Readiness Providing Accommodation for Medical Staff handling COVID-19 in Indonesia
JAKARTA, Indonesia, March 30, 2020 /PRNewswire/ -- Minister of Tourism and Creative Economy / Head of Tourism and Creative Economy Agency, Wishnutama Kusubandio - made sure that the hotels assigned to accommodate frontline medical personnel and task forces who are fighting the COVID-19 outbreak...
SHL Medical acquires Weibel CDS
ZUG, Switzerland, March 30, 2020 /PRNewswire/ -- SHL Medical, a pioneer and technology frontrunner in the self-injection industry, announced its acquisition of Weibel CDS, a medical technology company offering products and solutions for drug delivery and novel packaging. Weibel was established i...
Vinamilk donates nearly 500,000 USD to COVID-19 fight
HO CHI MINH CITY, Vietnam, March 30, 2020 /PRNewswire/ -- Thousands of samples
have been tested inVietnam for SARS-CoV-2 that causes COVID-19. However,
multiple others, including foreigners, have remained in quarantine at
residential areas and centralized quarantine centers.
CSPC Pharmaceutical Announces 2019 Annual Results
Profit Attributable To Shareholders Increased 20.6% to RMB3,714 Million Innovative Drug Business Continued to Deliver Strong Growth New Products Launched Helped to Sustain Growth HONG KONG, March 30, 2020 /PRNewswire/ -- CSPC Pharmaceutical Group Limited (HKEx: 01093) ("CSPC Pharmaceutical" or the...
Vela Diagnostics to offer manual ViroKey™ SARS-CoV-2 RT-PCR Test after completion of Emergency Use Authorization validation, targeted to be complete by early April 2020
SINGAPORE, March 30, 2020 /PRNewswire/ -- Ahead of Emergency Use Authorization (EUA) and in accordance with the U.S. Food and Drug Administration (FDA) Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency guidance document issued on March 16, 2020, Vela Diag...
Dominguez urges more support and delegated authority for President Asakawa so ADB can respond swiftly to COVID-19 crisis
MANILA, Philippines, March 30, 2020 /PRNewswire/ -- Finance Secretary Carlos Dominguez III of Department of Finance, Republic of the Philippines has urged his fellow governors at the Asian Development Bank (ADB) to empower its President Mr. Masatsugu Asakawa with more discretion in undertaking m...
Infinitus offers 800,000 epidemic prevention supplies packages free to help create a safe workplace at its exclusive stores
GUANGZHOU, China, March 29, 2020 /PRNewswire/ -- China has currently achieved initial success in preventing and controlling COVID-19, however, the overall situation remains serious. With the large-scale return to work and resumption of production now taking place across the country, workplace saf...
Ascentage Pharma Releases 2019 Annual Results, Reports Increased Investment in R&D and Advances in Global Clinical Development
SUZHOU, China and ROCKVILLE, MD, March 29, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today released its annual results for the...
Nano Retina Announces Preliminary Results for First-in-Human Implantation of Its NR600 Artificial Retina Device
The device is designed to restore vision to persons blinded by age-related macular degeneration and retinitis pigmentosa First two patients to receive the device in March 2020 report visual effect HERZLIYA, Israel, March 30, 2020 /PRNewswire/ -- Nano Retina Ltd., developer of the NR600, an artif...
Amerigo Education Responds to COVID-19 Impact
CHICAGO, March 29, 2020 /PRNewswire/ -- Amerigo Education, the leading provider of comprehensive boarding programs for international students, today shared its strategies to help protect students' health and wellbeing during the outbreak of coronavirus (COVID-19.) Amerigo started taking proactive...
Amerigo Education Responds to COVID-19 Impact
CHICAGO, March 30, 2020 /PRNewswire/ -- Amerigo Education, the leading provider of comprehensive boarding programs for international students, today shared its strategies to help protect students' health and wellbeing during the outbreak of coronavirus (COVID-19.) Amerigo started taking proactive...
Trip.com Group Chairman James Liang: Beware the xenophobia epidemic
SHANGHAI, March 29, 2020 /PRNewswire/ -- James Liang is an economist and entrepreneur. Trip.com Group Ltd. is one of the world's largest OTAs. The following are his thoughts on current events. These opinions are his own, and do not necessarily reflect those of Trip.com Group Ltd. as a whole: The...
Ping An Donates US$1.5 million of COVID-19 Medical Supplies to Indonesia
HONG KONG and SHANGHAI, March 28, 2020 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) announced that in response to the Extraordinary G20 Leaders' Summit's call to supportIndonesia in fighting the COVID-19 epidemic, Ping...
GenScript ProBio Congratulates XlifeSciences on the Start of TAEST16001 Early Phase Clinical Trial
NANJING, China, March 27, 2020 /PRNewswire/ -- Guangzhou XlifeSciences, a partner of GenScript ProBio (GenScript's CDMO segment) announced that the early phase clinical trial of TAEST16001 project has been started. GenScript ProBio extends congratulations on this. This clinical trial project is ...
GenScript ProBio Congratulates XlifeSciences on the Start of TAEST16001 Early Phase Clinical Trial
NANJING, China, March 27, 2020 /PRNewswire/ -- Guangzhou XlifeSciences, a partner of GenScript ProBio (GenScript's CDMO segment), announced that the early phase clinical trial of TAEST16001 project has been started. GenScript ProBio extends congratulations on this. This clinical trial project is...
Airbnb to Help Provide Housing to 100,000 COVID-19 Responders
* New global initiative will provide free or subsidized housing for healthcare professionals, relief workers, and first responders, typically closer to where they are working * Airbnb Hosts can opt in to provide homes that follow new cleanliness protocols based on recommendations from medica...
Foresee Pharmaceuticals and Accord Healthcare Announce MAA Submission for Camcevi(R) 42mg
TAIPEI, March 27, 2020 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee") and Accord Healthcare announced today that a Marketing Authorization Application (MAA) forCamcevi® 42mg (FP-001 LMIS 50mg), a ready-to-use 6-month depot formulation of leuprolide mesylate, has been su...
111 and Wenjiang People's Hospital to Build Online Cancer Diagnosis and Treatment Platform
SHANGHAI, March 27, 2020 /PRNewswire/ -- China's leading online pharmaceutical network and healthcare service provider is partnering with the Wenjiang People's Hospital inChengdu to build an online cancer diagnosis and treatment platform for rare tumors using imported drugs. The new rare tumor pl...
Week's Top Stories
Most Reposted
Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery
[Picked up by 323 media titles]
2025-01-13 09:05URBAN REVIVO Celebrates Lunar New Year with Unique Collaboration with Artist Mercedes Bellido
[Picked up by 294 media titles]
2025-01-13 10:44RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility
[Picked up by 287 media titles]
2025-01-14 21:00Gen Z Travelers Drive Buy Now, Plan Later Travel Bookings by Over 20%: Fliggy's 2024 Buy Now Plan Later Travel Insight
[Picked up by 286 media titles]
2025-01-10 16:04VANTAGE FOUNDATION SUPPORTS GRAB INDONESIA IN EMPOWERING WOMEN DRIVER-PARTNER
[Picked up by 280 media titles]
2025-01-09 18:26